Glob Bioenergi (ALGBE) - Total Liabilities
Based on the latest financial reports, Glob Bioenergi (ALGBE) has total liabilities worth €7.96 Million EUR (≈ $9.30 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Glob Bioenergi - Total Liabilities Trend (2008–2024)
This chart illustrates how Glob Bioenergi's total liabilities have evolved over time, based on quarterly financial data. See ALGBE working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Glob Bioenergi Competitors by Total Liabilities
The table below lists competitors of Glob Bioenergi ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Metgasco Ltd
AU:MEL
|
Australia | AU$13.81 Million |
|
Goldplat PLC
LSE:GDP
|
UK | GBX16.02 Million |
|
China Liberal Education Holdings
NASDAQ:CLEU
|
USA | $5.30 Million |
|
PBT Group Ltd
JSE:PBG
|
South Africa | ZAC103.88 Million |
|
LeddarTech Holdings Inc
NASDAQ:LDTC
|
USA | $134.89 Million |
|
Riverstone Energy Ltd
LSE:RSE
|
UK | GBX5.33 Million |
|
Cardiff Property PLC
LSE:CDFF
|
UK | GBX1.05 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down Glob Bioenergi's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALGBE market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.82 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Glob Bioenergi's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Glob Bioenergi (2008–2024)
The table below shows the annual total liabilities of Glob Bioenergi from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €7.96 Million ≈ $9.30 Million |
+1.42% |
| 2023-12-31 | €7.85 Million ≈ $9.17 Million |
-43.66% |
| 2022-12-31 | €13.93 Million ≈ $16.28 Million |
+6.15% |
| 2021-12-31 | €13.12 Million ≈ $15.34 Million |
-39.44% |
| 2020-12-31 | €21.67 Million ≈ $25.33 Million |
+18.78% |
| 2019-12-31 | €18.24 Million ≈ $21.32 Million |
-4.78% |
| 2018-12-31 | €19.16 Million ≈ $22.40 Million |
+11.81% |
| 2017-12-31 | €17.13 Million ≈ $20.03 Million |
+5.48% |
| 2016-12-31 | €16.24 Million ≈ $18.99 Million |
+13.49% |
| 2015-12-31 | €14.31 Million ≈ $16.73 Million |
+133.38% |
| 2014-12-31 | €6.13 Million ≈ $7.17 Million |
+126.86% |
| 2013-12-31 | €2.70 Million ≈ $3.16 Million |
-5.35% |
| 2012-12-31 | €2.86 Million ≈ $3.34 Million |
+54.62% |
| 2011-12-31 | €1.85 Million ≈ $2.16 Million |
+135.59% |
| 2010-12-31 | €784.00K ≈ $916.58K |
+14.62% |
| 2009-12-31 | €684.00K ≈ $799.67K |
+432.27% |
| 2008-12-31 | €128.51K ≈ $150.24K |
-- |
About Glob Bioenergi
Global Bioenergies SA is in the process of liquidation. Previously, the company was engaged in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. The company was incorporated in 2008 and is headquartered in Évry, France.